Improved strategies to control the epidemic of human immunodeficiency virus (HIV) type l are urgently needed. Research suggests that other sexually transmitted diseases (STDs) facilitate HIV transmission and may contribute substantially to the spread of AIDS. It is difficult, however, to establish the causal nature of the STD/HIV interaction in clinic based studies, due to potential confounding. In order to avoid this problem and to assess the impact of reduced STD levels on HIV incidence, we propose to conduct a prospective community based trial of intensive STD treatment and control. Twenty five randomly selected villages in Rakai District, Uganda, will receive the STD intervention, including a modified mass treatment strategy, serological surveillance, active case finding and intensive health education/condom distribution. An equal number of randomly chosen villages will serve as control communities, with equivalent data collection and preventive activities; however, instead of mass treatment, control subjects will be referred for STD treatment if warranted by symptomatology or serological results. The proposed study will build upon a large cohort study in the district. Cohort data indicate that the populations of the villages to be included have very high rates of HIV prevalence (range 10% - 58% for all adults), substantial HIV seroincidence (2.6% per 100 person years for adults aged 15-59), over 10% positive syphilis RPR, and over 10% of adults reporting genital ulcer or discharge on an annual basis. Cumulative follow-up rates have exceeded 80% over the 3 years of the current cohort study. We estimate that HIV and STD rates in this population are sufficiently high to detect a 35% reduction in HIV incidence in response to STD control, with 80% statistical power. Rakai District represents a unique setting for the proposed research, as no other study we know of is based in a similarly large number of villages with such high documented rates of both HIV and STDs. In the proposed modified mass STD treatment, we will use safe and effective drugs, administered as single dose oral regimens to both symptomatic and asymptomatic persons, and additional selected therapeutics provided on the basis of symptomatology, physical or laboratory diagnosis. This approach represents the optimum feasible strategy to ensure compliance, good population coverage and therapeutic efficacy in an underserviced area such as Rakai. The study will permit the testing of the mass treatment approach, a strategy of great potential value in other underserviced settings in the world. Due to the research nature of this project, the mass treatment will be backed up by intensive follow-up, surveillance and evaluation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034826-04
Application #
2376371
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1994-03-01
Project End
1999-02-28
Budget Start
1997-03-01
Budget End
1998-02-28
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Naluyima, Prossy; Eller, Michael A; Laeyendecker, Oliver et al. (2014) Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda. AIDS 28:1273-8
Redd, Andrew D; Laeyendecker, Oliver; Kong, Xiangrong et al. (2012) Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression. AIDS Res Hum Retroviruses 28:289-94
Stabinski, Lara; Reynolds, Steven J; Ocama, Ponsiano et al. (2011) High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther 16:405-11
Polis, Chelsea B; Gray, Ronald H; Bwanika, J B et al. (2011) Effect of hormonal contraceptive use before HIV seroconversion on viral load setpoint among women in Rakai, Uganda. J Acquir Immune Defic Syndr 56:125-30
Sagar, Manish; Laeyendecker, Oliver; Lee, Sandra et al. (2009) Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J Infect Dis 199:580-9
Laeyendecker, Oliver; Redd, Andrew D; Lutalo, Tom et al. (2009) Frequency of long-term nonprogressors in HIV-1 seroconverters From Rakai Uganda. J Acquir Immune Defic Syndr 52:316-9
Kiwanuka, Noah; Laeyendecker, Oliver; Quinn, Thomas C et al. (2009) HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 23:2479-84
Zablotska, Iryna B; Gray, Ronald H; Serwadda, David et al. (2006) Alcohol use before sex and HIV acquisition: a longitudinal study in Rakai, Uganda. AIDS 20:1191-6
Brahmbhatt, Heena; Kigozi, Godfrey; Wabwire-Mangen, Fred et al. (2006) Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 41:504-8
Kiddugavu, Mohammed G; Kiwanuka, Noah; Wawer, Maria J et al. (2005) Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 32:1-6

Showing the most recent 10 out of 41 publications